Filing Flows › 8-K events › BranchOut Food
BranchOut Food: entry into a material definitive agreement
Form 8-K filed Oct 26, 2026 · items 1.01, 8.01
Share offeringsBranchOut Food Inc. Announces $5.0 Million Underwritten Public Offering
What the filing says
On October 23, 2026, BranchOut Food Inc., a Nevada corporation, (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Lake Street Capital Markets LLC as the representative of the underwriters named therein (the “Representative” and any such other underwriters, the “Underwriters”), r
ScaleThe filing names $5.0M: about 28% of BranchOut Food's annual revenue ($17.8M, four times the latest quarter).
Read the filing on SEC EDGAR →
What usually followsAcross 23,525 8-Ks reporting Item 1.01 (material definitive agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.4%, up 51% of the time); over the following 21 sessions, +1.0%. Item 8.01: +0.1% next session across 44,881. Every item ranked →
What this kind of filing means
Item 1.01 — Entry into a material definitive agreement. A material agreement is one the company considers important enough to disclose within four business days: a merger agreement, a large supply or customer contract, a credit agreement or a licence. The terms often move the company’s outlook more than a quarter’s results.
BranchOut Food at a glance
BranchOut Food, Q2 2026: revenue $4.5M (+36% year over year), operating margin -57.5%. The chart follows the revenue to costs, profit and cash.
BranchOut Food: every quarter, Q/Q and Y/Y, holders and guidance →
BranchOut Food’s other material 8-Ks
- Oct 29, 2026 — Mergers and acquisitions BranchOut Food Announces Exercise of Over-Allotment Option in Public Offering
Other recent share offerings
- Airsculpt Technologies Nov 6, 2026
- Biovie Nov 6, 2026
- Clean Energy Technologies Nov 6, 2026
- Nextnrg Nov 6, 2026
- Paid Nov 6, 2026
- Silo Pharma Nov 6, 2026
- Agility Robotics Nov 6, 2026
- American Healthcare REIT Nov 6, 2026
- Entera Bio Nov 6, 2026
- Janus Living Nov 6, 2026
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.